Company Overview and News

52
10 Stocks That Every 20-Year-Old Should Buy

2018-09-14 investorplace
Investing in your 20s is not only smart, it’s exciting. The best part about creating a long-term portfolio — whether while going back to school or taking time off — is having the time to invest in undervalued companies. When looking at stocks to buy in your 20s, it’s all about opportunity cost, which is spent in spades throughout your late-teens and as an aimless 20-something. Long-term investors have the benefit of time, allowing them to ride out turbulence others can’t.
WFCNP FB NFLX GOOG GM BIDU WFC IBM TRIP WM EXPE BP BKNG GOOGL CVX SBUX PCLN

9
Expedia: Cheap, But Not Cheap Enough

2018-09-11 seekingalpha
Expedia operates in a growing OTA market. This market is highly fragmented. I believe this gives Expedia ample room for growth through acquisitions.
DESP EXPE BKNG CTRP TRIP GOOG

12
TripAdvisor Is Sitting On A Potential Gold Mine

2018-09-10 seekingalpha - 1
TripAdvisor business model still hinges on being an OTA. Nevertheless, its real value lies in its unique monthly users.
EXPE FB BKNG TRIP

2
TripAdvisor (TRIP) Up 5.2% Since Last Earnings Report: Can It Continue?

2018-08-31 zacks
It has been about a month since the last earnings report for TripAdvisor (TRIP - Free Report) . Shares have added about 5.2% in that time frame, outperforming the S&P 500.
TRIP

2
TripAdvisor Should Concentrate On Its Paid Ads

2018-08-20 seekingalpha
The paid ads is a concept which has a lot of potential, given the size of their platform and data stack.
TRIP

73
Best And Worst Performing S&P 500 Stocks On Earnings

2018-08-14 seekingalpha - 9
Below is a look at the 30 best and 30 worst performing S&P 500 stocks on their earnings reaction days this season. DISH Network (NASDAQ:DISH) posted a one-day gain of 14.53% on August 3rd following earnings, and that has held up as the best performer in the S&P 500 this season. Advanced Micro Devices (NASDAQ:AMD) ranks second with a one-day gain of 14.33%.
HAL GJV GLW FB DISH NWSA TRIP NLSN AMD EXPE WHR HAS NWS TWTR KHC INTC EBAY

38
Venture Capital Deals Of The Week: SoftBank Hands WeWork $1B

2018-08-11 seekingalpha - 1
Welcome to Seeking Alpha’s Venture Capital Deals of the Week. Follow this account and turn on the e-mail alert to receive VCDeals in your inbox on Saturday mornings.
NPSNY TEAM FB AVRO IPO TRIP SRPT BOLD GS GOOGL NVS MSFT ABBV PFE ABBV IPZYF EBAY

5
Solid Earnings Mean Yelp Stock Could Be Bound for All-Time Highs

2018-08-09 investorplace
Shares of Yelp (NASDAQ:YELP) are screaming higher Thursday, up more than 15% after the company reported second-quarter earnings results. Now trading near $44, is it possible for Yelp stock to rally to its former 52-week high at $48.40?
GOOGL TRIP GOOG

2
TRIP / TripAdvisor, Inc. S-8

2018-08-09 sec.gov
S-8 As filed with the Securities and Exchange Commission on August 9, 2018 Registration No. 333-
TRIP

9
Yelp: The Bears Were Wrong Again

2018-08-09 seekingalpha
The new no-term contract shift led to a record 17.1K new paying advertisers that will fuel future growth.
YELP TWTR TRIP

11
Klook Travel Startup Raises $200 Million to Go Global - Bloomberg

2018-08-07 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB EXPE TRIP

12
The Headwind Isn’t a Cyclical One for TRIP Stock

2018-08-05 investorplace
Tripadvisor (NASDAQ:TRIP) CEO Steve Kaufer put on a confident game face in the wake of Thursday’s disappointing second-quarter report, but owners of TRIP stock — current or prospective — weren’t buying it.
EXPE BKNG GOOGL TRIP GOOG TRVG

40
Top Analyst Upgrades and Downgrades: Blue Apron, Energy Transfer, Funko, Symantec, Teva, TripAdvisor and More

2018-08-03 247wallst - 3
The major equity indexes were indicated marginally lower after the payrolls report looked light prior to adding in higher revisions. That said, the drops were small and the Nasdaq was indicated marginally positive. Investors have had less success buying the all the stock market dips in 2018 than in prior years. Many investors also are reconsidering how they want their investments positioned ahead of the midterm elections and with international trade concerns.
SYMC UAA TEVA TEVVF MS APRN RUN DATA TRIP SYF FUN EOG UA ETP TEVJF FNKO TRI FL

2
Thursday’s Biggest Winners and Losers in the S&P 500

2018-08-02 247wallst
August 2, 2018: The S&P 500 closed up 0.6% at 2,827.33. The DJIA closed flat at 25,327.17. Separately, the Nasdaq was up 1.2% at 7,802.69.
TRIP CF

2
TripAdvisor (TRIP) Q2 2018 Results - Earnings Call Transcript

2018-08-02 seekingalpha
Good morning, and welcome to TripAdvisor's Second Quarter 2018 Earnings Conference Call. As a reminder, today's conference call is being recorded. At this time, I'd like to turn the conference call over to TripAdvisor's Vice President of Investor Relations, Mr. Will Lyons. Please go ahead.
TRIP

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to TRIP / TripAdvisor, Inc. on message board site Silicon Investor.

TRIPLE TRADES TRIPLE TRADES TRIPLE TRADES Make My Trip Make My Trip Make My Trip
TRPH TriPath Technology Inc. TRPH TriPath Technology Inc. TRPH TriPath Technology Inc. Mr. Pinku0027s triple pinky award scorecard. Mr. Pinku0027s triple pinky award scorecard. Mr. Pinku0027s triple pinky award scorecard.
VERY IMPORTANT- MY TRIP TO AMSTERDAM VERY IMPORTANT- MY TRIP TO AMSTERDAM VERY IMPORTANT- MY TRIP TO AMSTERDAM Olympic Hockey and Gay Strippers Olympic Hockey and Gay Strippers Olympic Hockey and Gay Strippers
Tripath Technology, Inc. (Nasdaq:TRPH) Tripath Technology, Inc. (Nasdaq:TRPH) Tripath Technology, Inc. (Nasdaq:TRPH) NTP - nexttrip.com NTP - nexttrip.com NTP - nexttrip.com
Nexttrip.Com (CDNX:NTP) Nexttrip.Com (CDNX:NTP) Nexttrip.Com (CDNX:NTP) RIOSUN--TRIPLED SINCE DEC 1st RIOSUN--TRIPLED SINCE DEC 1st RIOSUN--TRIPLED SINCE DEC 1st
CUSIP: 896945201